Researchers are excited about this new drug, a novel dual agonist showing remarkable outcomes in early trials for size loss . It works by modulating two pathways : GLP-1 and GIP, that , when engaged , help influence cravings and improve calorie burn. Initial observations suggest substantial weight loss and potential advantages for people facing obe